[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.



: Nanni C, Zanoni L, Bach-Gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-Baruch B, Teoh E, Ingram F, Fanti S, Schuster DM

Publisher: Springer

: 2020

: European Journal of Nuclear Medicine and Molecular Imaging

: European journal of nuclear medicine and molecular imaging

: Eur J Nucl Med Mol Imaging

: 47

: 3

: 579

: 591

: 13

: 1619-7070

: 1619-7089

DOI: https://doi.org/10.1007/s00259-019-04614-y


The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [18F]Fluciclovine PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of [18F]Fluciclovine PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.



Last updated on 2024-26-11 at 23:52